Radiol Oncol 2023; 57(1): 86-94. doi: 10.2478/raon-2022-0048 86 research article The spine and carina as a surrogate for target registration in cone-beam CT imaging verification in locally advanced lung cancer radiotherapy Jasna But-Hadzic1,2, Karmen Strljic1, Valerija Zager Marcius1,3 1 Department of Radiotherapy, Institute of Oncology Ljubljana, Ljubljana, Slovenia 2 Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia 3 Faculty of Health Sciences, University of Ljubljana, Department of Medical Imaging and Radiotherapy, Ljubljana, Slovenia Radiol Oncol 2023; 57(1): 86-94. Received 8 May 2022 Accepted 19 October 2022 Correspondence to: Valerija Žager Marciuš, Ph.D., Institute of Oncology Ljubljana, Zaloška 2, SI-100 Ljubljana, Slovenia E-mail: valerija.zager@zf.uni-lj.si; vzager@onko-i.si Disclosure: No potential conflicts of interest were disclosed. Th is is an open access article distributed under the terms of the CC-BY license (https://creativecommons.org/licenses/by/4.0/). Background. The aim of the study was to evaluate the accuracy of volumetric lung image guidance using the spine or carina as a surrogate to target for image registration, as the best approach is not established. Patients and methods. Cone beam computed tomography images from the 1st, 10th, 15th, and 20th fraction in 40 lung cancer patients treated with radical radiotherapy were retrospectively registered to planning CT, using three approaches. The spine and carina alignment set-up deviations from a reference (tumour/lymph nodes) registration in the lateral (LAT), longitudinal (LONG) and vertical (VRT) directions were analysed and compared. Tumour location and nodal stage influence on registration accuracy were explored. Results. The spine and carina mean set-up deviation from reference were largest in the LONG, with the best match in the VRT and LAT, respectively. Both strategies were more accurate in central tumours, with the carina being more precise in 50% LAT and 66% LONG mean deviations. For all measurements in all patients a carina vs. spine registration comparison showed improved carina accuracy in LAT and LONG. In comparative subgroup analysis the carina was superior compared to spine in LAT and LONG in centrally located tumours, N2 and N3. Both strategies were compa- rable for peripheral tumours and N0. Conclusions. Carina registration shows greater accuracy compared to spine in the LAT and LONG directions and is superior in central tumours, N2 and N3. The spine and carina surrogates are equally accurate for peripheral tumours and N0. We propose the carina as a surrogate to target for CBCT image registration in locally advanced lung cancer. Key words: locally advanced lung cancer; volumetric image verification; tumour registration; carina registration; spine registration; adaptive radiotherapy. Introduction Recent advances in systemic and radiotherapy treatment have resulted in improved survival for patients with inoperable locally advanced lung cancer.1 But still, nearly half of the patients will ex- perience locoregional relapse.2 The accuracy of dif- ferent steps in radiotherapy treatment preparation and execution have a strong impact on local con- trol.3 With the introduction of computed tomogra- phy (CT), positron emission computed tomogra- phy (PET CT) and four-dimensional (4D) CT simu- lation, the target delineation accuracy increased.4 Modern radiation techniques have enabled a more conformal dose delivery, the dose to normal tis- sue was reduced and the radical treatment of Radiol Oncol 2023; 57(1): 86-94. But-Hadzic J et al. / Accuracy of volumetric lung image guidance 87 more advanced N3 disease and/or dose escalation has become possible.5 Because of the steeper dose gradient and smaller safety margins, the accuracy of treatment delivery became increasingly impor- tant. For daily treatment position verification, cone beam CT (CBCT) largely replaced electronic portal imaging because of better soft-tissue visibility. The alignment of the treatment image with the plan- ning CT (pCT) is usually performed by radiation therapists (RTTs), who are not trained in target de- termination. The fast interpretation of CBCT is also challenging due to the lower quality of CBCT im- ages (no i.v. contrast) and changes with or adjacent to the tumour during treatment.6 Manual tumour matching is subjected to strong inter-observer var- iability even among radiation oncologists.7 The op- timal surrogate structure for image matching has not yet been established. Spine alignment is feasi- ble and reproducible, but shows poor correlation with tumour position.8 Recently, the carina surro- gate alignment was explored and showed superior reproducibility compared to spine alignment.7 We performed a retrospective study to deter- mine the accuracy of the carina vs. spine regis- tration compared to target (primary tumour and lymph nodes) registration as a reference. To avoid interobserver variability, reference registration was performed by individual thoracic radiation oncologist. To consider tumour and normal struc- ture variations during the course of treatment and their possible impact on image registration, the 1st, 10th, 15th, and 20th fraction CBCT were included in the registration analysis. Materials and methods Patient selection We retrospectively included 40 consecutive lung cancer patients treated with on-line cone-beam computer tomography (CBCT) image guided radi- cal radiotherapy from September 2018 to February 2019. All the patients had a visible tumour and/or lymph nodes on CT. They were treated with con- ventional, or hypofractionated volumetric modu- lated arc therapy on the Elekta Synergy linear accelerator (Elekta Synergy, Stockholm, Sweden). Clinical and treatment details were retrieved from medical records. Simulation and planning The planning CT scan was performed on the Big Bore CT simulator (Philips N.V., Eindhoven, NL), the Somatom Definition AS CT simulator (Siemens, Erlangen, D) and, in 6 patients, on Siemens Biograph mCT 40 (Siemens, Erlangen, D). The pa- tients were immobilised on a Posirest-2 (Civco, Coralville, USA) with the arms abducted above the head (36 patients) or with a long thermoplastic mask (4 patients). The gross tumour volume (GTV) was delineated as the visible tumour and patho- logic lymph nodes on free breathing pCT (with i.v. contrast). Additionally, 4D pCT was used for inter- nal target volume (ITV) delineation in 10 tumours. Planning was performed on the Monaco treatment planning system using the Monte Carlo calculation algorithm. Conventional fractionation (1.8–2 Gy daily dose) was used in 37 patients, and hypofrac- tionation in 3 (2.2, 2.2 and 2.75 Gy daily dose). The plan, pCT images and the delineated (target) con- tours were exported to the Elekta Synergy X-ray Volumetric Imaging (XVI) System. Imaging Kilovoltage gantry mounted CBCT systems were used for daily on-line CBCT treatment verification. According to physician instructions, localisation was based on automatic spine or carina matching between CBCT and pCT with additional manual translation correction by RTT. All set-up errors were corrected before treatment delivery. Study procedure Retrospective rigid image registration was done in the Elekta XVI System. We used the first treatment verification CBCT image from the 1st, 10th, 15th, and 20th fraction. The CBCT image was retrospectively registered with pCT based on three different strategies: (a) bony registration on the spine, (b) soft tissue regis- tration on the carina and (c) target (tumour/lymph node) matching on GTV/ITV. For 40 patients, we analysed 160 registration images and recorded 1440 corrections in the x (lateral – LAT), y (longi- tudinal – LONG) and z (vertical – VRT) directions. First two retrospective registrations on the spine and carina were performed by RTT and were based on automatic registration using a clip box (Figure 1). Residual translation errors were corrected manually, if necessary. Next, reference registra- tion on target (tumour/lymph node) matching was performed by an experienced thoracic radiation oncologist. Following automatic bone registra- tion, translational misalignments were manually Radiol Oncol 2023; 57(1): 86-94. But-Hadzic J et al. / Accuracy of volumetric lung image guidance88 corrected based on the visual adjustment of the GTV (ITV) contour on the CBCT image, to provide the best match for all known gross disease. If the lymph nodes were not visible, close anatomical surrogates were used. Translation corrections for target matching were recorded and used for the reference position. Spine and carina corrections were compared to the reference position and de- viations in LAT, LONG and VRT measurements were analysed. Statistics Microsoft Excel 2010 and the Statistical Package for the Social Sciences, version 25.0 (SPSS Inc., Chicago, IL, USA) were used. General data were presented with descriptive statistics. Kolmogorov-Smirnov and Shapiro-Wilk tests rejected normal data distri- bution. The Nonparametric Mann Whitney U test (MW), Wilcoxon Signed Ranks test and nonpara- metric Kruskal-Wally’s test (KW) were used for the analysis of the set-up deviation. The Wilcoxon Signed Ranks Test for dependent samples was used for comparison (pairwise). The KW and MW were used when we analysed the differences in a certain measurement according in two (MW) or into multiple groups (KW). A p value ≤ 0.05 was considered statistically significant. Results Patients, tumour and treatment characteristics The patients, disease and treatment characteris- tics are summarised in Table 1. Radiation was the primary treatment of “de novo” lung cancer in 80% of patients. One patient was treated for local progression of epidermal growth factor receptor (EGFR)+ adenocarcinoma and one had postop- erative regional recurrence. Five patients received reirradiation for local/regional recurrence. There were three plan adaptations after the 21st or 22nd fraction due to atelectasis (developing, resolution and worsening). Spine to target registration set-up deviation analysis The set-up deviation in the LAT, LONG and VRT directions for the spine according to target regis- tration for the 1st, 10th, 15th, and 20th fractions were analysed (Figure 2A). The best registration match was in the VRT direction, with a mean set-up devi- ation between 1.2 and 1.68 mm. The biggest devia- tion was detected in the LONG direction (2.03–2.73 mm). Deviation differences from the 1st through 20th fractions were not statistically significant in any direction. There was no time trend detected. Comparison of deviations between directions on the 20th fraction showed a significant set-up dif- ference in deviation between LAT vs. LONG (p = 0.002) and VRT vs. LONG (p = 0.000). The mean de- viation for all set-up measurements was 1.39 mm in LAT (SD 0.9, range 0–4.0 mm), 2.44 mm in LONG (SD 1.6, range 0.5–8.0 mm) and 1.36 mm in VRT direction (SD 1.04, range 0–4.75 mm). Carina to target registration set-up deviation analysis Analysis of the set-up carina registration devia- tions from the target set-up measurements for the 1st, 10th, 15th, and 20th fractions were also analysed (Figure 2B). The smallest set-up difference was in the LAT direction (from 0.9 to 1.8 mm). The larg- est discrepancies were detected in the LONG di- rection (from 1.53 to 2.15). The difference in de- viations for different fractions was not significant in any direction. There was no time trend in the deviations. Calculated from all the measurements, the mean deviation for the carina set-up deviations from the reference was 1.03 mm in LAT (SD 0.75, FIGURE 1. Automatic clip box carina registration with manual alignment check. Target contours (gross tumour volume [GTV] inner contour, planning target volume [PTV] outer contour) are imported for target registration. Radiol Oncol 2023; 57(1): 86-94. But-Hadzic J et al. / Accuracy of volumetric lung image guidance 89 range 0–3.75mm), 1.78 mm in LONG (SD 1.5, range 0–6.75mm) and 1.33 mm in the VRT direction (SD 1.25, range 0–5.25). Comparison of spine to target and carina to target set-up deviation differences The differences in the spine/target and carina/tar- get mean set-up deviations were compared indi- vidually for the different fractions and the mean for all measurements in all directions (Table 2). The registration on carina was more accurate ac- cording to the reference in all measurements ex- cept in the vertical direction on the 1st and 20th frac- tions. The only significant difference was found on the 10th fraction VRT direction, with the smallest deviation for carina registration. For all the measurements, registration on the ca- rina was significantly closer to the reference regis- tration in the LAT and LONG direction (p = 0.003 and p = 0.002, respectively). We found no differ- ence in the set-up deviation in the VRT direction for all measurements. The impact of tumour location (central/ peripheral) and N stage on the spine/ target and carina/target registration deviation Analysis of the spine registration deviations from the reference showed a significantly better regis- tration match for centrally located tumours in LAT on the 1st and 10th fractions, in LONG on the 1st fraction and in VRT on the 10th fraction (Table 3). The carina/target registration comparison showed significantly smaller differences for cen- tral tumours in 50% LAT measurements (10th and 15th fraction), in 2/3 LONG measurements (10th –20th fraction), but not in the VRT direction (Table 4). We found no impact of the node stage on the spine/target registration deviations. When the carina was used for alignment, the differences were significantly smaller for N2 and N3 in the LAT 15th, LAT 20th, LONG 15th and VRT 20th frac- tion (p = 0.034, 0.028, 0.025 and 0.034, respectively) (Supplementary Tables S1–S2). Possible time trend for spine/target LAT deviation difference was de- tected for central tumours (Table 3). TABLE 1. Patients, disease, and treatment characteristics N = 40 Gender Female 16 (40 %) Male 24 (60 %) Age (years) Median (range) 67 (53–81) Tumour location* RUL 15 (37.5%) RML 3 (7.5%) RLL 7 (17.5%) LUL 8 (20%) LLL 8 (20%) Central (C)/ peripheral (P) tumour location** C 17 (42.5%) P 22 (55%) Histology NSCLC 31 (77.5%) SCLC 9 (22.5%) Disease treated De novo lung cancer 32 (80%) Local progression 1 (2.5%) Local recurrence reirradiation 2 (5%) Regional recurrence 1 (2.5%) Locoregional recurrence reirradiation 4 (10%) Systemic treatment Concurrent chemotherapy 13 (32.5%) Sequential chemotherapy 16 (40%) Target therapy 1 (2.5%) None 10 (25%) Tumour (T) stage T0 1 (2.5%) T1 4 (10%) T2 14 (35%) T3 8 (20%) T4 13 (32.5%) Lymph nodes (N) stage N0 9 (22.5%) N1 1 (2.5%) N2 14 (35%) N3 16 (40%) Fractionation Conventional 37 (92.5%) Hypofractionation 3 (7.5%) Radiation technique VMAT 40 (100%) * In one patient, two synchronous tumours were treated (RUL and LUL). **In one patient, only the lymph nodes were treated (regional recurrence). LLL = left lower lobe; LUL = left upper lobe; NSCLC = non-small cell cancer; RML = right middle lobe; RLL = right lower lobe; RUL = right upper lobe; SCLC = small cell lung cancer; VMAT = volumetric modulated arc therapy Radiol Oncol 2023; 57(1): 86-94. But-Hadzic J et al. / Accuracy of volumetric lung image guidance90 FIGURE 2. Spine to target (A) and carina to target (B) registration set-up deviation in the lateral (LAT), longitudinal (LONG) and vertical (VRT) directions. A B Radiol Oncol 2023; 57(1): 86-94. But-Hadzic J et al. / Accuracy of volumetric lung image guidance 91 The impact of tumour location (central/ peripheral) and N stage on the spine/ target vs. carina/target deviation differences The deviation differences analysis between the spine/target and carina/target registration accord- ing to tumour location and N stage is shown in Supplementary tables S3–S5. For peripherally lo- cated tumours, the carina registration deviation was only smaller compared to the spine set-up de- viation in the 1st fraction LONG with a deviation difference of 1.91mm (p = 0.034). In centrally located tumours, the registration on carina was found to be significantly more accurate on the 15th and 20th frac- tions LAT, (p = 0.012 and 0.048, respectively), the 15th and 20th fractions LONG (p = 0.010 and 0.011, respectively) and for all LAT and LONG measure- ments (p = 0.003). The deviation differences were 0.76, 0.94, 1.59, 1.35, 0.5 and 0.71mm, respectively. There was no difference in the set-up deviation in the VRT direction regardless of tumour location. Comparison of the deviation differences ac- cording to the N stage showed a better correlation between the carina and target registration for N2 and N3 disease. We found deviation differences TABLE 2. Mean set-up deviation difference (DD) comparison according to spine/target vs. carina/target registration Fraction LAT deviation mean (mm) p value LONG deviation mean (mm) p value VRT deviation mean (mm) p valueSpine/ target Carina/ target DD Spine/ target Carina/ target DD Spine/ target Carina/ target DD 1st 1.28 0.90 0.38 NS 2.65 1.80 0.85 NS 1.20 1.43 -0.23 NS 10th 1.30 1.08 0.22 NS 2.03 1.53 0.50 NS 1.68 1.10 0.58 0.04 15th 1.48 1.08 0.4 NS 2.38 1.65 0.73 0.05 1.38 1.38 0 NS 20th 1.53 1.05 0.48 NS 2.73 2.15 0.58 NS 1.2 1.43 -0.23 NS All measurements 1.39 1.03 0.37 0.003 2.44 1.78 0.66 0.002 1.36 1.33 0.03 NS DD = deviation difference; LAT = lateral; LONG = longitudinal; NS = non-significant (p>0.05); target = primary tumour and lymph nodes; VRT = vertical TABLE 3. Spine/target registration deviation according to tumour location Fraction LAT mean (mm) p value LONG mean (mm) p value VERT mean (mm) p value Central Peripheral Central Peripheral Central Peripheral 1st 0.71 1.77 0.048 1.18 3.91 0.002 1.12 1.32 NS 10th 0.76 1.77 0.008 1.53 2.41 NS 1.41 1.86 0.017 15th 1.47 1.55 NS 2.59 2.32 NS 1.35 1.45 NS 20th 1.94 1.27 NS 2.29 3.14 NS 1.29 1.09 NS LAT = lateral; LONG = longitudinal; NS = non significant (p>0.05); target = primary tumour and lymph nodes; VRT = vertical TABLE 4. Carina/target registration deviation according to tumour location Fraction LAT mean (mm) p value LONG mean (mm) p value VERT mean (mm) p value Central Peripheral Central Peripheral Central Peripheral 1st 0.65 1.14 NS 1.65 2.00 NS 1.06 1.77 NS 10th 0.53 1.55 0.002 1.18 1.86 0.041 0.82 1.32 NS 15th 0.71 1.41 0.049 1.00 2.23 0.027 0.88 1.77 NS 20th 1.00 1.14 NS 0.94 3.14 0.019 0.88 1.82 NS LAT = lateral, LONG = longitudinal, NS = non significant (p>0.05); VRT = vertical; target = primary tumour and lymph nodes Radiol Oncol 2023; 57(1): 86-94. But-Hadzic J et al. / Accuracy of volumetric lung image guidance92 of 0.63mm N2 and 1.17mm N3 in LONG, 0.48mm N3 in LAT for all measurements and 0.94mm N3 10th fraction LONG (p = 0.013, 0.015, 0.002 and 0.007, respectively). A small but significant 0.5mm differ- ence in favour of the carina registration was found for N0 in all measurements LAT (p = 0.034). Because only 1 patient had the N1 stage, we excluded his measurements from this analysis (Supplementary Table S5). Discussion Since the introduction of CBCT into treatment verification, new insights to target position uncer- tainties have evolved6, suggesting that image guid- ance could currently be the weakest link in the ra- diotherapy procedure.3,9 Only a few studies have explored the carina as a surrogate in volumetric lung image guidance7,10,11 and there is a lack of knowledge in this field. Here we present new data on the accuracy of the carina vs. spine surrogate compared to the target alignment as a reference in image registration. A separate analysis of the spine and carina reg- istration set-up differences compared to the ref- erence (target) registration showed the smallest differences in the VRT and LAT directions, with the largest deviation in the LONG direction for both strategies (Fig. 2). The differences were not significantly different in time and no time trend was detected for the cohort, so we evaluated all the measurements together and again showed a good registration match in the VRT and LAT directions, but in LONG direction, the range of misalignment reached above 5 mm in both registration strategies. The greatest area of uncertainty in the LONG di- rection was also shown in the study by Ottosson et al. where they compared the spine and target reg- istration in free-breathing and breath-hold CBCT in locally advanced lung cancer patients. The largest intra- and inter-fractional misalignments were found in the LONG direction, independent of the registration method.12 Although we found a smaller mean LONG misalignment in the carina vs. spine registration (1.78 vs. 2.44 mm), uncertain- ties in image registration should be considered for both strategies, with the enlargement of the PTV in the craniocaudal (CC) direction. To determine the best registration match com- pared to the reference, we compared differences in the set-up deviations for the spine and carina alignment. Both strategies were equally accurate in the VRT direction, but the carina was more accu- rate in the LONG and LAT directions in all meas- urements. The accuracy of the spine vs. carina reg- istration was also tested in a study by a Canadian group, where four independent observers auto- matically and manually aligned the first fraction CBCT with the pCT in 30 lung cancer patients.7 They used spine, carina and tumour registration strategies. Automatic spine and carina registra- tions provided similar tumour coverage, with the tumour inside the ITV in 60% of observations. The same group, in a second study, verified the tumour (T) and lymph node (LN) coverage following spine and carina registration for initial, middle, and final fraction CBCT. Both strategies improved the com- bined target coverage throughout the treatment course compared to tattoo alignment. Carina bet- ter improved the combined coverage and showed significantly superior nodal coverage compared to the spine, without compromising primary tumour coverage.10 With a significantly better registration match in the LONG and LAT directions, our data supports the suggestion from the Canadian group that the carina may be superior to the spine in the image guidance of locally advanced lung cancer. The second Canadian study showed similar pri- mary tumour coverage, regardless of the registra- tion strategy.10 But in our study, the registration ac- curacy was influenced by tumour location. Both the spine and carina alignment showed smaller set-up differences for centrally located tumours with the difference being more significant in the carina reg- istration LONG (66% fractions) and LAT (50% frac- tions). For peripheral tumours, we found no differ- ence in the accuracy of spine vs. carina alignment, but for centrally located tumours, the carina was more accurate in the LAT and LONG directions. Our data suggests that the carina is a better sur- rogate for centrally located tumours. Importantly, we also showed that the carina is as accurate as the spine for registration in peripherally located tumours and can be proposed as a registration sur- rogate regardless of the tumour location. According to our data, carina matching can also be used regardless of the nodal stage. We found no differences in the spine, but a better match for ca- rina alignment in N2 and N3 disease. In advanced nodal disease, the carina showed superior registra- tion vs. the spine in LAT and LONG. The finding is in concordance with the second Canadian study, where carina matching improved the node cover- age compared to spine registration.10 Importantly, we found no set-up difference for N0 disease sug- gesting that the carina and spine can equally be used as a surrogate in this stage. As there was Radiol Oncol 2023; 57(1): 86-94. But-Hadzic J et al. / Accuracy of volumetric lung image guidance 93 only a single case of early nodal disease, we can- not make any conclusions for N1. The reliability of spine matching for LN coverage was investigated in the study by Mohammed et al., where an equal geographical target miss was found for spine vs. combined target matching, but inferior LN cover- age in the case of tumour matching, based on a weekly 4D CBCT registration.9 Because the same geographical miss was shown for hilar and medi- astinal lymph nodes, we can hypothesize that ca- rina matching could safely be used in N1 as well. Target alignment should be “the ground truth” and have an impact on the therapeutic ratio,3,12 but is rather difficult to implement clinically. Due to the poor soft tissue contrast on CBCT and tu- mour changes during the course of treatment, only half of the tumours can clearly be contoured using CBCT.13 For these reasons, we used con- toured-based registration for reference. A similar approach was used for target coverage and geo- graphical miss assessments studies9,10 and target registration in the study by Ottosson et al.12 Direct tumour registration is also impractical because it is time-consuming and unreliable due to high intra-observer variability.7 In contrast, the carina is clearly visible on the CBCT and automatic ca- rina alignment shows high reproducibility, supe- rior even to spine alignment.7 Although the carina shows some respiratory movement, especially in the CC direction, it is still an excellent surrogate for directly adjacent mediastinal lymph nodes. Preliminary data also suggests a good correlation between the carina and GTV motion.7,11 We acknowledge the limitations of our study, which was retrospective and relatively small. We also present a heterogeneous group of patients, though they represent real everyday radiothera- pists’ lung cancer patients. In our study, CBCT im- age changes were not systematically determined. Because the majority of changes appear in the first five weeks of radiotherapy,14 we analysed CBCT images from the 1st, 10th, 15th and 20th fractions. Maybe the 25th and 30th fraction CBCT should have been included since we found cases for plan modi- fication in the 6th week of treatment. Nevertheless, we detected no significant set-up differences in time. The rate of plan adaptation was low (7.5%), suggesting the need for a “traffic light” protocol implementation.3 In conclusion, carina registration was shown to be feasible, fast, and reproducible. Our data shows that, compared to target registration, carina is equally as accurate as spine registration, with su- perior accuracy in the LONG and LAT directions. The carina is a better surrogate than the spine for alignment in centrally located tumours, N2 and N3 disease. Although spine alignment can equally be used in N0 and peripheral tumours, for simplic- ity we propose that the carina should be the pri- mary surrogate for the target in image guidance in locally advanced lung cancer. The next step should be to incorporate carina registration uncertainties into the PTV margin. Acknowledgement This research was supported by Slovenian re- search programme for comprehensive cancer con- trol SLORApro (P3-0429). Reference 1. Spigel DR, Faivre-Finn C, Gray JE, Vicente D, Planchard D, Paz-Ares LG, et al. Five-year survival outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC: an update from the PACIFIC trial. J Clin Oncol 2021; 39: 8511-11. doi: 10.1200/JCO..39.15_suppl.8511 2. Vrankar M, Stanic K, Jelercic S, Ciric E, Vodusek AL, But-Hadzic J. Clinical outcomes in stage III non-small cell lung cancer patients treated with durvalumab after sequential or concurrent platinum-based chemoradio- therapy - single institute experience. Radiol Oncol 2021; 55: 482-90. doi: 10.2478/raon-2021-0044 3. Tvilum M, Khalil AA, Møller DS, Hoffmann L, Knap MM. Clinical outcome of image-guided adaptive radiotherapy in the treatment of lung cancer patients. Acta Oncol (Madr) 2015; 54: 1430-7. doi: 10.3109/0284186X.2015.1062544 4. Mercieca S, Belderbos JSA, van Herk M. Challenges in the target volume definition of lung cancer radiotherapy. Transl Lung Cancer Res 2021; 10: 1983-98. doi: 10.21037/tlcr-20-627 5. Chan C, Lang S, Rowbottom C, Guckenberger M, Faivre-Finn C. Intensity-modulated radiotherapy for lung cancer: current status and future developments. J Thorac Oncol 2014; 9: 1598-608. doi: 10.1097/ JTO.0000000000000346 6. Clarke E, Curtis J, Brada M. Incidence and evolution of imaging changes on cone-beam CT during and after radical radiotherapy for non-small cell lung cancer. Radiother Oncol 2019; 132: 121-6. doi: 10.1016/j.ra- donc.2018.12.009 7. Higgins J, Bezjak A, Franks K, Le LW, Cho BC, Payne D, et al. Comparison of spine, carina, and tumor as registration landmarks for volumetric image- guided lung radiotherapy. Int J Radiat Oncol Biol Phys 2009; 73: 1404-13. doi: 10.1016/j.ijrobp.2008.06.1926 8. Purdie TG, Bissonnette J-P, Franks K, Bezjak A, Payne D, Sie F, et al. Cone- beam computed tomography for on-line image guidance of lung ste- reotactic radiotherapy: localization, verification, and intrafraction tumor position. Int J Radiat Oncol Biol Phys 2007; 68: 243-52. doi: 10.1016/j. ijrobp.2006.12.022 9. Mohammed N, Kestin L, Grills I, Shah C, Glide-Hurst C, Yan D, et al. Comparison of IGRT registration strategies for optimal coverage of primary lung tumors and involved nodes based on multiple four-dimensional CT scans obtained throughout the radiotherapy course. Int J Radiat Oncol Biol Phys 2012; 82: 1541-8. doi: 10.1016/j.ijrobp.2011.04.025 10. Lavoie C, Higgins J, Bissonnette J-P, Le LW, Sun A, Brade A, et al. Volumetric image guidance using carina vs spine as registration landmarks for conven- tionally fractionated lung radiotherapy. Int J Radiat Oncol Biol Phys 2012; 84: 1086-92. doi: 10.1016/j.ijrobp.2012.02.012 Radiol Oncol 2023; 57(1): 86-94. But-Hadzic J et al. / Accuracy of volumetric lung image guidance94 11. van der Weide L, van Sörnsen de Koste JR, Lagerwaard FJ, Vincent A, van Triest B, Slotman BJ, et al. Analysis of carina position as surrogate marker for delivering phase-gated radiotherapy. Int J Radiat Oncol Biol Phys 2008; 71: 1111-7. doi: 10.1016/j.ijrobp.2007.11.027 12. Ottosson W, Rahma F, Sjöström D, Behrens CF, Sibolt P. The advantage of deep-inspiration breath-hold and cone-beam CT based soft-tissue registra- tion for locally advanced lung cancer radiotherapy. Radiother Oncol 2016; 119: 432-7. doi: 10.1016/j.radonc.2016.03.012 13. Lim G, Bezjak A, Higgins J, Moseley D, Hope AJ, Sun A, et al. Tumor regression and positional changes in non-small cell lung cancer dur- ing radical radiotherapy. J Thorac Oncol 2011; 6: 531-6. doi: 10.1097/ JTO.0b013e31820b8a52 14. Elsayad K, Kriz J, Reinartz G, Scobioala S, Ernst I, Haverkamp U, et al. Cone- beam CT-guided radiotherapy in the management of lung cancer: diagnostic and therapeutic value. Strahlenther Onkol 2016; 192: 83-91. doi: 10.1007/ s00066-015-0927-y